Difference between revisions of "Hao NB, et al. Clin. Dev. Immunol. (2012) cited as Ref 454 in DOI: 10.1038/s41392-020-0110-5 (Q9717)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2012, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Clin. Dev. Immunol., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Clin. Dev. Immunol. | ||
| Property / Published In Name String: Clin. Dev. Immunol. / rank | |||
| + | Normal rank | ||
Revision as of 21:01, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hao NB, et al. Clin. Dev. Immunol. (2012) cited as Ref 454 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hao NB
0 references
2012
0 references
Clin. Dev. Immunol.
0 references
